Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.
about
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsCD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequenceCoevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cellsCanonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.Joining the immunological dots in recurrent miscarriage.A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia.Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors.Influence of molecular genetics in Vogt-Koyanagi-Harada disease.Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis.Expression patterns of killer cell immunoglobulin-like receptors (KIR) of NK-cell and T-cell subsets in Old World monkeysAssociation between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.KIR/HLA interactions and pathogen immunityNK cells, innate immunity and hepatitis C infection after liver transplantation.p21(WAF1/CIP1) RNA expression in highly HIV-1 exposed, uninfected individualsFrequency of killer cell immunoglobulin-like receptors (KIRs) in Korean patients with chronic HCV infection.Examining the role of components of Slc11a1 (Nramp1) in the susceptibility of New Zealand sea lions (Phocarctos hookeri) to disease.Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug usersLysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.Hla-Cw7 allele as predictor of favorable therapeutic response to interferon-alpha in patients with chronic hepatitis C.Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype.KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cellsKiller cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.A Systems Biology Approach to Characterize Biomarkers for Blood Stasis Syndrome of Unstable Angina Patients by Integrating MicroRNA and Messenger RNA Expression ProfilingImmunogenetic contributions to recurrent pregnancy lossRegulation of immunity in bronchiectasis.Potential role of killer immunoglobulin receptor genes among individuals vaccinated against hepatitis B virus in Lebanon.Human papillomavirus, high-grade intraepithelial neoplasia and killer immunoglogulin-like receptors: a Western Australian cohort study.Natural killer cell receptors and their ligands in liver diseases.Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes.Natural killer cells: versatile roles in autoimmune and infectious diseases.Roles and mechanism of natural killer cells in clinical and experimental transplantation.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation.Are killer cell immunoglobulin-like receptor genes important for the prediction of kidney graft rejection?Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy.A modified FCCS procedure applied to Ly49A-MHC class I cis-interaction studies in cell membranesCell mediators of autoimmune hepatitis and their therapeutic implications.Diversity of killer cell immunoglobulin-like receptor genes in uveitis associated with autoimmune diseases: ankylosing spondylitis and Behçet disease.
P2860
Q21144323-B2B25D6D-2025-4F26-953C-A3B549C06139Q27650047-E127F94E-D568-473D-BE4E-DBE466184E79Q28743223-73F9E57A-C7B4-4233-BE60-E435C5525F89Q30252783-ADD30FD5-524D-4B82-A295-CEF75774795CQ33349212-4EA6D2C1-16BE-40CF-85C5-66733C6D1F18Q33421329-1B994844-38A8-4A1A-BD1C-5E3D5E385537Q33598281-21EBFD67-CBC5-4AD4-B055-ADDD79EDA218Q33929571-D4B9EC9F-291C-4958-B117-FCEE899FBD2CQ34145864-19602C03-3BDA-4D05-BE2A-0044373A398AQ34536026-9C19557D-FE0B-48BE-9B68-674FD4FF64AEQ34746563-D444C634-5B31-4CF1-9ECA-94895AB61A9AQ34823295-DB00B8DD-D688-4DC8-AB5F-70558C47190CQ34995326-2C3CE770-A273-460F-8A0B-F59F6C3F7027Q35001169-EC1ABBA1-974A-4ECE-9A6E-D790650B734FQ35019869-68AA34DC-76A1-460C-9872-6EBB42CB515EQ35154844-9B53FB27-BB42-4621-9D24-E8D11B219454Q35511598-96B77CD4-42F7-4973-B9E6-200929FB976CQ35601612-5662FC4E-38AB-44F0-98E7-773255B37DDDQ35660526-40101A82-572F-424C-8805-48A16D41CFC7Q36064034-E3B7A631-E53C-400C-8517-A6A7599FCDB5Q36405322-7AA7DDE8-5E7E-4097-89FE-832A5947BB74Q36415029-4F959E4C-50D4-40B5-B108-E494873CA0BAQ36532802-903DAD9F-2D68-4DC8-9346-E90F0C9394CBQ36569959-3A8DA541-1C40-4083-9CA2-3129722B42D4Q36883314-008C4C1E-B39D-4040-8F11-8D24FD0AE983Q37059982-E5CA023E-EE00-48A7-8DDE-B3F677029364Q37209962-E1E22D2F-C379-4651-955C-DB010E5816E6Q37345255-5DD9FBFF-C26A-495C-A5F1-75AFE030C948Q37356179-68101370-DEB3-4636-BC1B-69FFE3FB9C69Q37417170-7A8A573C-E59D-4F8F-BD98-A8B5CD417687Q37599963-38EBD7B5-09C7-4CFA-988C-51CFC47C46B5Q37754682-4B81853F-7B83-4FC2-9FCF-124B7880BB65Q37755212-9B15C864-BD30-44ED-84BD-65112D68838AQ37854081-17300B6C-DF1D-4CE1-BBDB-8DA87F8AF353Q38071293-010020F8-4786-46B5-9731-8868CB7D0B7AQ38095763-4DA03D96-BEBD-4D80-8A81-C64C3552BC4DQ38258624-D243E69D-C134-4F88-9314-7EBC918F1E37Q38273065-7B6CF92A-12F7-4FAA-B60B-6D841FFF5309Q38285331-8A18537C-3A57-4EE5-B948-37D495AF9312Q38450189-DA8C6E95-B9F8-4B58-97BD-C2373013B3C7
P2860
Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Natural killer cells, killer i ...... te antigen class I in disease.
@en
type
label
Natural killer cells, killer i ...... te antigen class I in disease.
@en
prefLabel
Natural killer cells, killer i ...... te antigen class I in disease.
@en
P2860
P1476
Natural killer cells, killer i ...... te antigen class I in disease.
@en
P2093
D M Altmann
R J Boyton
P2860
P356
10.1111/J.1365-2249.2007.03424.X
P577
2007-05-22T00:00:00Z